Skip to content
10-Q

Quarterly Report

AIMMUNE THERAPEUTICS, INC.

0001564590-20-034973

← back to feed
Filed
Jul 30, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Jul 24, 2020 65.45M sh
Capex Q2 2020 · Jun 30, 2020 $807K
Capex Q2 2020 · Jun 30, 2019 $4.86M
Operating Cash Flow Q2 2020 · Jun 30, 2020 −$126.9M
Operating Cash Flow Q2 2020 · Jun 30, 2020 −$126.92M
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$92M
Long Term Debt Q2 2020 · Jun 30, 2020 $131.46M
Long Term Debt Q2 2020 · Dec 31, 2019 $41.03M
Cash And Equivalents Q2 2020 · Jun 30, 2020 $266.56M
Cash And Equivalents Q2 2020 · Dec 31, 2019 $79.88M
Stockholders Equity Q2 2020 · Jun 30, 2020 $179.86M
Stockholders Equity Q2 2020 · Mar 31, 2020 $235.05M
Stockholders Equity Q2 2020 · Dec 31, 2019 $104.02M
Stockholders Equity Q2 2020 · Jun 30, 2019 $204.97M
Stockholders Equity Q2 2020 · Mar 31, 2019 $256.3M
Stockholders Equity Q2 2020 · Dec 31, 2018 $298.95M
Current Liabilities Q2 2020 · Jun 30, 2020 $43M
Current Liabilities Q2 2020 · Dec 31, 2019 $47.45M
Total Liabilities Q2 2020 · Jun 30, 2020 $185.43M
Total Liabilities Q2 2020 · Dec 31, 2019 $100.35M
Current Assets Q2 2020 · Jun 30, 2020 $323.64M
Current Assets Q2 2020 · Dec 31, 2019 $149.08M
Total Assets Q2 2020 · Jun 30, 2020 $365.29M
Total Assets Q2 2020 · Dec 31, 2019 $204.37M
Sga Expense Q2 2020 · Jun 30, 2020 $38.09M
Sga Expense Q2 2020 · Jun 30, 2020 $87.23M
Sga Expense Q2 2020 · Jun 30, 2019 $31.2M
Sga Expense Q2 2020 · Jun 30, 2019 $54.91M
Rd Expense Q2 2020 · Jun 30, 2020 $23.05M
Rd Expense Q2 2020 · Jun 30, 2020 $59.51M
Rd Expense Q2 2020 · Jun 30, 2019 $31.99M
Rd Expense Q2 2020 · Jun 30, 2019 $63.3M
Net Income Q2 2020 · Jun 30, 2020 −$69.24M
Net Income Q2 2020 · Jun 30, 2020 −$155.68M
Net Income Q2 2020 · Mar 31, 2020 −$86.43M
Net Income Q2 2020 · Jun 30, 2019 −$62.88M
Net Income Q2 2020 · Jun 30, 2019 −$117.14M
Net Income Q2 2020 · Mar 31, 2019 −$54.27M
Operating Income Q2 2020 · Jun 30, 2020 −$65.99M
Operating Income Q2 2020 · Jun 30, 2020 −$151.27M
Operating Income Q2 2020 · Jun 30, 2019 −$63.19M
Operating Income Q2 2020 · Jun 30, 2019 −$118.22M
Cost Of Revenue Q2 2020 · Jun 30, 2020 $4.85M
Cost Of Revenue Q2 2020 · Jun 30, 2020 $5.11M
Revenue Q2 2020 · Jun 30, 2020 $575K